Averion International Corp. Continues Growth In Europe
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTC BB: AVRO), an international clinical research organization (CRO) specializing in oncology, cardiovascular diseases and medical devices, today announced it has further strengthened its European operations by opening an office in the Czech Republic.